Start of a new era in fight against drug resistant TB

Thursday 12 December

WHO released a rapid communication on the treatment of drug resistant (DR) and extensively drug resistant (XDR) tuberculosis (TB). This puts an ‘end to tears’, for painful daily injections in […]

7th European Advanced Course in Clinical Tuberculosis

Wednesday 20 November

The 7th European Advanced Course in Clinical Tuberculosis (TB) offered an informative and interactive program with national and international speakers with a comprehensive experience in the field of clinical tuberculosis […]

3HP regimen soon to be accessible in Malawi

Thursday 31 October

KNCV Tuberculosis Foundation Malawi welcomes the substantial reduction in the price of the anti-tuberculosis drug rifapentine, announced today at the Union World Conference on Lung Health in India. “For people […]

Important price reduction improves access to TB prevention

Thursday 31 October

KNCV Tuberculosis Foundation welcomes the announcement of a substantial reduction in the price of an anti-tuberculosis medicine through the support of Unitaid and the Global Fund, in partnership with the […]

Innovative TB treatment support project kicks off in the Philippines

Wednesday 25 September

ASCENT aims to assist patients succeed in treatment using digital adherence technology. On World Lung Day, the innovative TB treatment support project ASCENT kicks off in the Philippines, making the […]

Antacid helps tuberculosis bacteria to survive

Sunday 1 September

In 2017, some 10 million people suffered from tuberculosis and 1.6 million died of the disease. One reason why infection with Mycobacterium tuberculosis is so difficult to treat is that […]

FDA approval of BPaL regimen an important breakthrough in TB control

Wednesday 14 August

The US Food & Drug Administration (FDA) today approved pretomanid for the treatment of highly drug-resistant forms of tuberculosis (TB) in a combination regimen known as BPaL. This regimen was […]

ASCENT: Empowering patients through digital technology

Tuesday 23 July

GENEVA/THE HAGUE, The next three and a half years, KNCV Tuberculosis Foundation will lead the innovative ASCENT project, which stands for Adherence Support Coalition to End TB. This brand new […]

Call to Action for awareness on AMR

Thursday 20 June

KNCV Tuberculosis Foundation is one of the civil society organizations that signs the Call to Action for awareness on antimicrobial resistance (AMR) in the Netherlands. Kitty van Weezenbeek, director of […]

Wolfheze Workshops 2019: inspiring knowledge exchange & concrete steps forward

Tuesday 28 May

KNCV Tuberculosis Foundations can look back at an inspiring edition of the Wolfheze Workshops 2019 (15-17 May). In Scheveningen 160 TB experts from over 40 countries from Western Europe, Eastern […]

Unique gathering of TB and HIV experts in Scheveningen

Wednesday 15 May

Biennial Wolfheze Workshops focuses on alarming tandem of infectious diseases THE HAGUE, 15 May 2019 International experts in the field of tuberculosis (TB) and HIV control meet today in Scheveningen […]

Dutch civil society calls upon increase of Dutch commitment to the Global Fund

Friday 12 April

The Hague – This week, KNCV Tuberculosis Foundation, in cooperation with Aidsfonds and nine other Dutch civil society organisations* called upon the Dutch Minister for Trade and Development Cooperation, Sigrid […]